WIRED Science: Space, Health, Biotech, and More

Crispr'd Cells Show Promise in First US Human Safety Trial

WIRED Science: Space, Health, Biotech, and More

It’s been over three years since US regulators greenlit the nation’s first in-human test of Crispr’s disease-fighting potential, more than three years of waiting to find out if the much-hyped gene-editing technique could be safely used to beat back tough-to-treat cancers. Today, researchers from the University of Pennsylvania and Stanford finally revealed the first published report describing the trial.

Next Episodes